Inhibition of the PI3K pathway in vivo determines a well-known toxicity spectrum (hyperglycemia, skin rash, diarrhea, and mucositis) that is often difficult to manage (Chia et al., 2015; Esposito et al., 2019). The gene discussed is PIK3CA; the disease is Hyperglycemia.